University of California, Irvine Health

Orange, California 92868-3201

4 studies enrolling now · 19 studies all time

What they study most

Acid Maltase Deficiency, Acute Respiratory Distress Syndrome, Adult, Acute T Cell Leukemia Lymphoma, Anaplastic Lymphoma Kinase-positive, Bone Cancer, Bone Metastases, Bone Neoplasm, Breast Neoplasms, Cancer, Carcinoma, Hepatocellular, Cervical Cancer, Chronic Graft-Versus-Host Disease (cGVHD)

Studies at this site

• Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy — Recruiting now
• Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC — Recruiting now
• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) — Recruiting now
• A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD) — Recruiting now
• MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas — Running, not enrolling
• A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System foR the tREatment of Vascular Lesions Located in the infrapoplitEal Arteries beLow the Knee (DEEPER REVEAL) — Completed
• Phase 1 Trial of LVGN6051 as Single Agent and in Combination With Keytruda (Pembrolizumab) in Advanced or Metastatic Malignancy — Completed
• Add-on Reparixin in Adult Patients With ARDS — Completed
• 9-ING-41 in Patients With Advanced Cancers — Running, not enrolling
• Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer — Completed
• Electroacupuncture in Symptom Management After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy — Running, not enrolling
• A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors — Completed
• Study on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic Therapy — Stopped early
• UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma — Completed
• A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE) — Running, not enrolling
• Convalescent Plasma to Limit SARS-CoV-2 Associated Complications — Completed
• Neutralizing Antibody Seroprevalence Study With a Retrospective Component in Participants With Late-Onset Pompe Disease — Completed
• Convalescent Plasma to Stem Coronavirus (CSSC-001) — Completed
• Transurethral Ultrasonic Imaging For Detection and Classification of Prostate Cancer — Stopped early